- Peptic ulcer
- Duodenal ulcer
- Gastrointestinal reflux disease
- Zollinger-Ellison syndrome
Mechanism of Action:
Rabeprazole inhibits the secretion of gastric acid in the stomach by acting on the hydrogen potassium ATPase (H+, k+ATPase) pump present on parietal cells.
Rabeprazole act as prodrug, it only gets activated in the acid environment of the stomach.
Pharmacokinetics:
Absorption-
It is absorbed orally and its bioavailability is about 52%
Protein Binding-
It is 93% bound to plasma proteins
Metabolism-
It is metabolized in the liver
Excretion-
90% of the drug is excreted via urine
- Bloating
- Swelling of faces and arms
- Rapid weight gain
- Tiredness
- Weakness
- Yellowing of eyes
- Light coloured stools
- Tingling of hands and feet’s
- Contraindicated in liver disorders
- Contraindicated in systemic lupus erythematous
- Contraindicated in hypomagnesaemia
- Aspirin
- Ibuprofen
- Lorazepam
- Atorvastatin
- Metoprolol succinate
- Omeprazole
- Pantoprazole
- Paracetamol